<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 26, 1999
-----------------------
Oncor, Inc.
--------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Maryland
--------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-16177 52-1310084
- ---------------------------------- -----------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
209 Perry Parkway, Gaithersburg, Maryland 20877
--------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(301) 963-3500
--------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
N.A.
--------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
Item 5. Other Events
- ------- ------------
1. Joseph Shaya has been elected Acting President and Chief Executive
Officer.
2. See attached press release.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Oncor, Inc.
--------------------------------------------
(Registrant)
By: /s/ Joseph R. Shaya
----------------------------------
Name: Joseph R. Shaya
Title: Acting President and Chief Executive
Officer
Dated: March 3, 1999
<PAGE> 4
PRESS RELEASE
- -------------------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: ONCOR, INC.
- --------------------------------
Joseph R. Shaya 209 Perry Parkway
Acting President and CEO Gaithersburg, MD 20877
(301) 963-3500
Fax (301) 330-3940
- -------------------------------------------------------------------------------
FOR IMMEDIATE RELEASE
ONCOR, INC. FILES ORDER OF RELIEF IN THE UNITED STATES BANKRUPTCY
COURT FOR THE DISTRICT OF DELAWARE
GAITHERSBURG, MARYLAND -- FEBRUARY 26, 1999 . . . ONCOR, INC. announced that
the Company and its wholly-owned subsidiary, Codon Pharmaceuticals, Inc., filed
voluntary petitions for relief under Chapter 11 of the United States Code today
in the United States Bankruptcy Court for the District of Delaware. The
Company intends to reorganize its financial affairs.
Oncor and Codon, both based in Gaithersburg, Maryland, are engaged in the
development of genetic testing systems for the detection and management of
significant life-threatening cancers and the development of genetic therapies,
including gene-repair compounds.
# # #
